Hyperthermia for locally advanced breast cancer

References

• Haagensen CD, Stout AP. Carcinoma of the breast. II: Criteria of operability. Ann Surg 1943; 118: 1032–1051
   PubMedGoogle Scholar
• Greene FL, Balch CM, Fleming ID, April F. AJCC Cancer Staging Manual6th. Philadelphia 2003
   Google Scholar
• Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB, Jr, Fisher ER, Wickerham DL, Wolmark N, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15: 2483–2493
   PubMed Web of Science ®Google Scholar
• Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, Margolese R, Theoret H, Soran A, Wickerham DL, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol 2003; 21: 4165–4174
   PubMed Web of Science ®Google Scholar
• Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 2004; 22: 4067–4074
   PubMed Web of Science ®Google Scholar
• Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, et al. Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project protocols B-18 and B-27. J Clin Oncol 2008; 26: 778–785
   PubMed Web of Science ®Google Scholar
• McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SC, Yu T, Strom EA, Oh JL, Woodward WA, Tereffe W, et al. Postmastectomy radiation improves the outcome of patients with locally advances breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1004–1009
   PubMed Web of Science ®Google Scholar
• Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh J, Domain D, Yu T, Woodward WA, Tereffe W, Singletary SE, et al. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1155–1160
   PubMed Web of Science ®Google Scholar
• Haagensen CD, Stout AP. Carcinoma of the breast II: Criteria of operability. Ann Surg 1943; 118: 859–870
   PubMedGoogle Scholar
• Haagensen CD, Cooley E. Radical mastectomy for mammary carcinoma. Ann Surg 1969; 170: 884–888
   PubMed Web of Science ®Google Scholar
• Fracchia AA, Evans JF, Eisenberg BL. Stage III carcinoma of the breast–A detailed analysis. Ann Surg 1980; 192: 705–710
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN, Singletary SE, Buchholz TA. Locally advanced breast cancer. Advanced therapy of breast disease2nd, SE Singletary, GL Robb, GN Hortobagyi. BC Decker, Ontario 2004; 498–508
   Google Scholar
• Skinner KA, Dunnington G, Silberman H, Florentine B, Spicer D, Formenti SC. Preoperative 5-fluorouracil and radiation for locally advanced breast cancer. Am J Surg 1997; 174: 705–708
   PubMed Web of Science ®Google Scholar
• Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R. Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive phase I/II trials. Int J Radiat Oncol Biol Phys 2005; 61: 1045–1053
   PubMed Web of Science ®Google Scholar
• Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 1992; 10: 102–110
   PubMed Web of Science ®Google Scholar
• Shen ZZ, Zhang YW, Pan TX, Xia CJ. Multidisciplinary approach to the treatment of unresectable breast cancer. World J Surg 1995; 19: 843–846
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Takatsuka Y, Hasegawa S, Yongman K, Kondo M, Hirao T, Kan K, Tono T, Ohzato H, Imamoto H, et al. Intra-arterial chemotherapy to improve quality of life in cases of unresectable advanced or recurrent breast cancer. Gan To Kagaku Ryoho 1998; 25: 1341–1343
   PubMedGoogle Scholar
• Petera J, Filip S, Slampa P, Soumarova R, Coupek P, Zatloukal P. Management of inoperable carcinoma of the breast by curative radiotherapy and chemo-hormonotherapy. Onkologie 2001; 24: 263–266
   PubMedGoogle Scholar
• Silva JA, Perez M, Rivera S, Olivares G, Lira-Puerto V, Castaneda N, Morales F, Calderillo G, Alcedo JC, Onate-Ocana F, et al. Phase II study of neo-adjuvant gemcitabine plus epirubicin in primarily unresectable locally advanced breast cancer. Breast J 2008; 14: 397–398
   PubMed Web of Science ®Google Scholar
• Pignon JP, le Maitre A, Maillard E, Bourhis J. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4–14
   PubMed Web of Science ®Google Scholar
• Auperin A, le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010; 28: 1–10
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–5812.
   Google Scholar
• Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994; 86: 441–446
   PubMed Web of Science ®Google Scholar
• Mason KA, Kishi K, Hunter N, Buchmiller L, Akimoto T, Komacki R, Milas L. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer Res 1999; 5: 4191–4198
   PubMed Web of Science ®Google Scholar
• Formenti SC, Symmans WF, Volm M, Skinner K, Cohen D, Spicer D, Danenberg PV. Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol 1999; 9: 34–42
   PubMed Web of Science ®Google Scholar
• Kosma K, Koukourakis M, Skarlatos J, Zambatis C, Ardavanis A, Beroukas K, Yannakakis D. Hypofractionated radiotherapy with 5-fluorouracil radiosensitization for locally ‘far advanced’ breast cancer. Am J Clin Oncol 1997; 20: 562–566
   PubMed Web of Science ®Google Scholar
• Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, Bettini AC, Groshen S, Gee C, Florentine B, et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial. J Clin Oncol 2003; 21: 864–870
   PubMed Web of Science ®Google Scholar
• Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, et al. Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer. Clin Cancer Res 2006; 12: 1570–1576
   PubMed Web of Science ®Google Scholar
• Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Seymour MMA. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys 2000; 48: 393–397
   PubMed Web of Science ®Google Scholar
• Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro. Int J Radiat Biol Relat Stud Phys Chem Med 1971; 19: 467–477
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dikomey E. Hyperthermic radiosensitization: Mode of action and clinical relevance. Int J Radiat Biol 2001; 77: 399–408
   PubMed Web of Science ®Google Scholar
• Raaphorst GP, Ng CE, Yang DP. Thermal radiosensitization and repair inhibition in human melanoma cells: A comparison of survival and DNA double strand breaks. Int J Hyperthermia 1999; 15: 17–27
   PubMed Web of Science ®Google Scholar
• Dewhirst MW. Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol 1998; 8: 143–150
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Sim DA, Grochowski KJ. Thermal influence on radiation induced complications versus tumor response in a phase III randomized trial. Hyperthermic oncology 1984, J Overgaard. Taylor & Francis, Philadelphia 1984; 1: 313–316
   Google Scholar
• Sim DA, Oleson JR, Grochowski KJ. An update of the University of Arizona human clinical hyperthermia experience including estimates of therapeutic advantage. Hyperthermic oncology 1984, J Overgaard. Taylor & Francis, Philadelphia 1984; 1: 367–370
   Google Scholar
• Luk KH, Pajak TF, Perez CA, Johnson RJ, Connor N, Dobbins T. Prognostic factors for tumor response after hyperthermia and radiation. Hyperthermic oncology 1984, J Overgaard. Taylor & Francis, Philadelphia 1984; 1: 353–356
   Google Scholar
• Valdagni R, Liu F, Kapp DS. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int J Radiat Oncol Biol Phys 1988; 15: 959–972
   PubMed Web of Science ®Google Scholar
• Oleson JR, Sim DA, Manning MR. Analysis of prognostic variables in hyperthermia treatment of 161 patients. Int J Radiat Oncol Biol Phys 1984; 10: 2231–2239
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Rosen EL, Blackwell KL, Jones EL, Brizel DM, Prosnitz LR, Samulski TV, Dewhirst MW. Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia 2003; 19: 498–506
   PubMed Web of Science ®Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, Brizel DM, Vujaskovic Z. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 2004; 10: 4287–4293
   PubMed Web of Science ®Google Scholar
• Iemwananonthachai N, Pattaranutaporn P, Chansilpa Y, Sukkasem M. Hyperthermia in combination with radiation therapy for treatment for advanced inoperable breast cancer. J Med Assoc Thai 2003; 86: 715–721
   PubMedGoogle Scholar
• Hiraoka M, Nishimura Y, Nagata Y, Mitsumori M, Okuno Y, Li PY, Abe M, Takahashi M, Masunaga S, Akuta K. Site-specific phase I, II trials of hyperthermia at Kyoto University. Int J Hyperthermia 1994; 10: 403–410
   PubMed Web of Science ®Google Scholar
• Lyng H, Rofstad EK. Treatment failure following sequential thermoradiotherapy of locally advanced breast carcinoma occurs primarily in poorly vascularized tumors. Oncology 1995; 52: 443–447
   PubMed Web of Science ®Google Scholar
• Bornstein BA, Zouranjian PS, Hansen JL, Fraser SM, Gelwan LA, Teicher BA, Svensson GK. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 79–85
   PubMed Web of Science ®Google Scholar
• Herman TS, Jochelson MS, Teicher BA, Scott PJ, Hansen J, Clark JR, Pfeffer MR, Gelwan LE, Molnar-Griffin BJ, Fraser SM. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys 1989; 17: 1273–1279
   PubMed Web of Science ®Google Scholar
• Lyng H, Monge OR, Bohler PJ, Rofstad EK. Changes in temperatures and thermal doses with fraction number during hyperthermic treatment of locally advanced breast carcinoma. Int J Hyperthermia 1991; 7: 815–825
   PubMed Web of Science ®Google Scholar
• Lyng H, Monge OR, Bohler PJ, Rofstad EK. Temperature distribution in locally advanced breast carcinoma during hyperthermic treatment: Relationship to perfusion, vascular density, and histology. Int J Radiat Oncol Biol Phys 1991; 21: 423–430
   PubMed Web of Science ®Google Scholar
• Lyng H, Monge OR, Bohler PJ, Rofstad EK. Relationships between thermal dose and heat-induced tissue and vascular damage after thermoradiotherapy of locally advanced breast carcinoma. Int J Hyperthermia 1991; 7: 403–415
   PubMed Web of Science ®Google Scholar
• Masunaga S, Hiraoka M, Takahashi M, Jo S, Akuta K, Nishimura Y, Nagata Y, Abe M. Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer–comparison of results with radiotherapy alone. Int J Hyperthermia 1990; 6: 487–497
   PubMed Web of Science ®Google Scholar
• Li RY, Lin SY, Zhang TZ. Assessment of combined thermoradiotherapy in recurrent of advanced carcinoma of the breast. Adv Exp Med Biol 1990; 267: 521–523
   PubMedGoogle Scholar
• Hofman P, Knol RGF, Lagendijk JW, Schipper J. Thermoradiotherapy of primary breast carcinoma. Int J Hyperthermia 1989; 5: 1–11
   PubMed Web of Science ®Google Scholar
• Vora N, Forell B, Joseph C, Lipsett J, Archambeau JO. Interstitial implant with interstitial hyperthermia. Cancer 1982; 50: 2518–2523
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Hamaguchi Y, Ichikawa Y, Shimura M, Kawano N, Nakatani Y, Ohnishi H, Maegawa J, Ogino I, Shimada H. Locally advanced mucinous carcinoma of the breast with sudden growth acceleration: A case report. Jpn J Clin Oncol 2002; 32: 64–67
   PubMed Web of Science ®Google Scholar
• Yamasaki M, Yayoi E, Kishibuchi M, Nishi M, Yagyu T, Kawasaki K, Ostapenko V, Nishide T. A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy. Gan To Kagaku Ryoho 2001; 28: 1746–1748
   PubMedGoogle Scholar
• Wiedemann G, Mella O, Coltart RS, Schem BC, Dahl O. Hyperthermia improves local tumor control in locally advanced breast cancer. Klin Wochenschr 1988; 66: 1034–1038
   PubMedGoogle Scholar
• Ostapenko VV, Yamazaki M, Nishide Y, Tanaka H, Miyano M, Sonobe M, Toda K, Mune M, Nishide I, Yukawa S. Long-term local hyperthermia in the treatment of advanced breast cancer (case report). Anticancer Res 2001; 21: 4117–4119
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, Craciunescu O, Stauffer P, Liotcheva V, Betof A, Blackwell K. A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. Int J Hyperthermia 2010; 26: 514–521
   PubMed Web of Science ®Google Scholar
• Bear HD, Anderson S, Smith RE, Geyer CE, Jr, Mamounas EP, Fisher B, Brown AM, Robidoux A, Margolese R, Kahlenberg MS, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol 2006; 24: 2019–2027
   PubMed Web of Science ®Google Scholar
• Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK, Liotcheva VB, Jones EL, Vujaskovic Z, Marks J, et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 2006; 12: 819–826
   PubMed Web of Science ®Google Scholar
• Craciunescu OI, Blackwell KL, Jones EL, Macfall JR, Yu D, Vujaskovic Z, Wong TZ, Liotcheva V, Rosen EL, Prosnitz LR, et al. DCE-MRI parameters have potential to predict response of locally advanced breast cancer in patients to neoadjuvant chemotherapy and hyperthermia: A pilot study. Int J Hyperthermia 2009; 25: 405–415
   PubMed Web of Science ®Google Scholar
• Hand JW, Machin D, Vernon CC, Whaley JB. Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 1997; 13: 343–364
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WLJ, van Rhoon GC, van Dijk JDP, Gonzalez Gonzalez D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Welz S, Hehr T, Lamprecht U, Scheithauer H, Budach W, Bamberg M. Thermoradiotherapy of the chest wall in locally advanced or recurrent breast cancer with marginal resection. Int J Hyperthermia 2005; 21: 159–167
   PubMed Web of Science ®Google Scholar